Supplements and Featured Publications
Abriendo Puertas a los Profesionales con el Multimodal Maestro2
The Only Branded Steroid Indicated for Inflammation Associated with a Range of Ocular Surface Conditions
A Reliable Treatment for Blepharitis/Meibomian Gland Dysfunction, with Increased Ocular Bioavailability
Glaucoma 360: Highlights from 2021
Glaucoma 360: Highlights from 2020
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Glaukos receives FDA approval for Epioxa topical therapy for keratoconus
2
Dompé's NAION program selected for FDA Commissioner’s National Priority Voucher Program
3
Aurion Biotech releases positive 12-month results from phase 1/2 CLARA trial
4
AAO 2025: Diana Do, MD, reviews the real-world use of aflibercept 8 mg
5
.png "Optometry Times"){kind=logo}
